Related Funds
Funds with similar focus
Fund Name | Location |
Blade LLC | Boston, Massachusetts, United States |
BNP Paribas Fortis | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
CKA Capital Ltd | England, London, United Kingdom |
Contrary | California, San Francisco, United States |
Hua Capital | Beijing, Beijing, China |
Huayu Investment | Beijing, Beijing, China |
Jet Propulsion Laboratory | California, Pasadena, United States |
Jilin Investment Group | China, Jilin, Jilin |
Kingfisher Capital LLC | - |
Launch It Capital Ltd. | Israel, Tel Aviv, Tel Aviv District |
Life Is Too Short Capital | Guerrero, Mexico, San Pedro |
Minghao | - |
NS Solutions | Japan, Tokyo |
PIA | Japan, Minato |
REALITY ACCELERATOR | Chiyoda, Japan |
Reflexion Capital | France, Ile-de-France, Paris |
Shenzhen Hexie Fazhan Touzi | China, Guangdong, Shenzhen |
Softfir Capital | - |
Suruga Bank | Japan, Numazu, Shizuoka Prefecture |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
LeadBio Tech | $15M | 13 Nov 2023 | Hangzhou, Zhejiang, China | ||
Waker Biology | 20 Dec 2022 | Minhang, Shanghai, China | |||
Yingshu Life | 22 Nov 2022 | Shenzhen, Guangdong, China | |||
Ubrigene | $15M | 01 Sep 2022 | - | ||
Hemu Gene | $4M | 15 Aug 2022 | China, China | ||
YZY Bio | $38M | 13 Sep 2021 | Wuhan, Hubei, China | ||
Realmind Biotech | 19 Jul 2021 | Nanjing, Jiangsu, China | |||
ToloBio | $1M | 07 Aug 2020 | Shanghai, Shanghai, China | ||
Targene Medical | $15M | 27 Mar 2020 | Yuexiu District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
LeadBio Tech | $15M | 13 Nov 2023 | Hangzhou, Zhejiang, China | ||
Waker Biology | 20 Dec 2022 | Minhang, Shanghai, China | |||
Yingshu Life | 22 Nov 2022 | Shenzhen, Guangdong, China | |||
Ubrigene | $15M | 01 Sep 2022 | - | ||
Hemu Gene | $4M | 15 Aug 2022 | China, China | ||
YZY Bio | $38M | 13 Sep 2021 | Wuhan, Hubei, China | ||
Realmind Biotech | 19 Jul 2021 | Nanjing, Jiangsu, China | |||
ToloBio | $1M | 07 Aug 2020 | Shanghai, Shanghai, China | ||
Targene Medical | $15M | 27 Mar 2020 | Yuexiu District, Guangdong Province, China |